PS
TAK icon

Principal Securities’s Takeda Pharmaceutical TAK Stock Holding History

Principal Securities’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$163K Buy
+10,165
New +$168K ﹤0.01% 1525
2025
Q4 		– Sell
-5,228
Closed -$76.5K – 3270
2025
Q3 		$76.5K Buy
5,228
+594
+13% +$8.82K ﹤0.01% 1732
2025
Q2 		$71.6K Buy
4,634
+768
+20% +$11.3K ﹤0.01% 1695
2025
Q1 		$51.2K Hold
3,866
– – ﹤0.01% 1753
2024
Q4 		$51.2K Buy
3,866
+638
+20% +$8.76K ﹤0.01% 1752
2024
Q3 		$45.9K Buy
3,228
+396
+14% +$5.62K ﹤0.01% 1729
2024
Q2 		$36.6K Buy
2,832
+56
+2% +$741 ﹤0.01% 1762
2024
Q1 		$38.6K Buy
2,776
+797
+40% +$11.6K ﹤0.01% 1691
2023
Q4 		$28.2K Buy
+1,979
New +$28.1K ﹤0.01% 1744

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Principal Securities's TAK Position: Q2 2026 in Review

Principal Securities opened a new position in Takeda Pharmaceutical (TAK) in Q2 2026: 10,165 shares worth $163K. The stake represents ﹤0.01% of the portfolio and ranks #1525 among its holdings. This is a return to the name: Principal Securities previously reported a position in TAK as recently as Q3 2025.

Principal Securities first reported a position in TAK in Q4 2023 and has held it in 9 quarters since. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Principal Securities held 10,165 shares of Takeda Pharmaceutical worth $163K as of Q2 2026.
  • Takeda Pharmaceutical was a new Principal Securities position in Q2 2026.
  • Takeda Pharmaceutical made up ﹤0.01% of Principal Securities's portfolio in Q2 2026, its #1525 holding.
  • Principal Securities first reported a position in Takeda Pharmaceutical in Q4 2023 and has held it in 9 quarters since.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Principal Securities's 13F filing for Q2 2026, filed 4 Aug 2026.